GlassScriptPhysician profile
Alberto L Fernandez
NPI 1215959952
$24,947.07
in general payments reported to CMS, 2019-2025
46 companies · $2,857 in 2025
The $2,857 reported for 2025 was more than what 82% of Pulmonary Disease providers received nationally (typical 2025 total: $500).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,293 · 2020: $11K · 2021: $2,773 · 2022: $1,610 · 2023: $1,844 · 2024: $3,347 · 2025: $2,857.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $4,813 · Travel and Lodging: $3,235.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $4,813.20 |
| Travel and Lodging | $3,235.08 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $7,504.07 | 2019-2025 | Nucala |
| Mylan Specialty L.P. | $6,099.03 | 2020-2022 | |
| Abiomed | $1,751.70 | 2023-2025 | Impella |
| Ethicon INC. | $1,662.53 | 2021-2025 | Monarch Platform |
| Medical Device Business Services, INC. | $1,652.00 | 2023-2024 | Na, Monarch |
| Veran Medical Technologies, INC. | $723.81 | 2019-2020 | |
| Galvanize Therapeutics, INC | $682.97 | 2025 | Aliya System |
| Astrazeneca Pharmaceuticals LP | $641.09 | 2019-2025 | Andexxa, Tezspire, Breztri |
| Intuitive Surgical, INC. | $494.10 | 2025 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $473.50 | 2021-2025 | Ofev |
| Pulmonx Corporation | $433.60 | 2024-2025 | Chartis Catheter, Zephyr Delivery Catheter, Pulmonx Chartis Tablet Console |
| Electromed, INC. | $382.92 | 2019-2025 | Smartvest |
| Insmed, INC. | $325.91 | 2021-2025 | Arikayce, Brinsupri |
| Actelion Pharmaceuticals US, INC. | $260.83 | 2021-2024 | Opsumit, Uptravi |
| Regeneron Healthcare Solutions, INC. | $239.77 | 2019-2025 | Dupixent |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $165.48 | 2025 | Symplicity G3 |
| United Therapeutics Corporation | $156.19 | 2019-2025 | Tyvaso |
| Medivance, INC. | $123.42 | 2019 | |
| Ethicon US, LLC | $104.43 | 2022 | |
| Genzyme Corporation | $100.79 | 2023-2025 | |
| Merck Sharp & Dohme LLC | $96.43 | 2021-2024 | Belsomra, Keytruda |
| Jazz Pharmaceuticals INC. | $69.64 | 2021-2022 | |
| Takeda Pharmaceuticals U.S.A., INC. | $65.16 | 2021-2022 | |
| Covidien LP | $64.11 | 2019 | |
| Verona Pharma, INC. | $58.36 | 2025 | Ohtuvayre |
| Baxter Healthcare | $49.22 | 2025 | Hillrom - Vest System Model 105 Home Care |
| Stryker Corporation | $46.63 | 2025 | Flowtriever |
| Lilly USA, LLC | $45.39 | 2025 | Zepbound |
| Abbvie INC. | $45.08 | 2023 | |
| Axsome Therapeutics, INC. | $45.04 | 2024 | Sunosi |
| Philips North America LLC | $44.53 | 2019 | |
| Sunovion Pharmaceuticals INC. | $40.43 | 2019 | |
| Amgen INC. | $40.29 | 2025 | Tezspire |
| Grifols USA, LLC | $36.81 | 2019-2023 | Prolastin-C Liquid |
| Ani Pharmaceuticals, INC. | $30.95 | 2024 | Purified Cortrophin Gel |
| Inogen, INC. | $28.80 | 2022-2025 | |
| Avadel Cns Pharmaceuticals, LLC | $25.65 | 2025 | Lumryz |
| Csl Behring | $19.28 | 2022 | |
| Resmed Corp | $18.68 | 2022 | |
| Harmony Biosciences LLC | $16.53 | 2023 | Wakix |
| Fisher & Paykel Healthcare INC | $16.10 | 2021 | |
| Mallinckrodt Hospital Products INC. | $14.29 | 2025 | Acthar |
| Alexion Pharmaceuticals, INC. | $13.52 | 2021 | |
| Portola Pharmaceuticals, LLC | $13.14 | 2019 | |
| Tactile Systems Technology INC | $12.92 | 2023 | Flexitouch Plus, Entre Plus |
| Melinta Therapeutics, LLC | $11.95 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alberto Fernandez listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.